News Release

Interim safety of RSVpreF vaccination during pregnancy

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: In this interim reporting of respiratory syncytial virus prefusion F (RSVpreF) vaccine safety in a large cohort of pregnancies with vaccine-seeking behavior, this study found no statistically significant increases in any prespecified safety outcomes compared with unvaccinated pregnancies.

Corresponding Author: To contact the corresponding author, Ashley I. Michnick, PharmD, PhD, email ashley_michnick@hphci.harvard.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.23452)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.23452?guestAccessKey=51cde4ab-4f97-4b53-95f6-9e5b7e069a67&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010826

 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.